Lisata Therapeutics(LSTA) - 2024 Q2 - Earnings Call Transcript

Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q2 2024 Earnings Conference Call August 12, 2024 4:30 AM ET Company Participants John Menditto - VP, IR & Corporate Communications David Mazzo - President & CEO James Nisco - Chief Accounting Officer Kristen Buck - EVP, Research and Development & Chief Medical Officer Conference Call Participants Steve Brozak - WBB securities Sara Nik - H.C. Wainwright Will Hidell - Brookline Capital Markets Pete Enderlin - MAZ Partners Robert Sassoon - Water Tower Research Operator W ...